Luyao Shen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Luyao Shen has a total of 181 co-authors. Here are the top co-authors by number of shared publications:
- Justin Ruey Tse
Department of Radiology, Stanford University, Stanford, USA
16 shared publications - Aya Kamaya
Department of Radiology, Stanford Medical Center, Stanford, Calif
15 shared publications - Luke Yoon
Department of Radiology, Stanford University School of Medicine, Stanford, USA
6 shared publications - Lindsey M. Negrete
Department of Radiology, Stanford University School of Medicine, Stanford, USA
5 shared publications - Priyanka Jha
Stanford University, Stanford, USA
5 shared publications - Tie Liang
Department of Radiology, Stanford University School of Medicine, Stanford, USA
5 shared publications
Latest Publications
- 1 September 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 320 (3)
Diagnostic Accuracy of Bosniak v2019 for Predicting Cancer and Unfavorable Histology in Class III–IV Cystic Renal Masses
This multicenter multinational study demonstrated that Bosniak classification version 2019 can be used to stratify the probability of cancer and cancer with unfavorable histologic features; nodule size was strongly associated with unfavorable histologic features.
- 1 September 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 320 (3)
Diagnostic Accuracy of Bosniak v2019 for Predicting Cancer and Unfavorable Histology in Class III–IV Cystic Renal Masses
This multicenter multinational study demonstrated that Bosniak classification version 2019 can be used to stratify the probability of cancer and cancer with unfavorable histologic features; nodule size was strongly associated with unfavorable histologic features.
- 1 May 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319 (2) , e252310
Benign Lesions Scored as O-RADS US v2022 4 and 5 Categories: Prevalence and Morphologic Analysis
Solid components and multilocularity were frequently found among benign lesions scored as Ovarian-Adnexal Reporting and Data System (O-RADS) 4 or 5, with cystadenomas and cystadenofibromas being the most common benign lesions.
- 1 May 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319 (2) , e252310
Benign Lesions Scored as O-RADS US v2022 4 and 5 Categories: Prevalence and Morphologic Analysis
Solid components and multilocularity were frequently found among benign lesions scored as Ovarian-Adnexal Reporting and Data System (O-RADS) 4 or 5, with cystadenomas and cystadenofibromas being the most common benign lesions.
- 20 March 2026
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (10) , 1-9
Site-specific limitations of ctDNA in PDAC surveillance: imaging detects pulmonary and local recurrence missed by liquid biopsy
Objectives To evaluate the concordance between circulating tumor DNA (ctDNA) and imaging in the postoperative surveillance of patients with resected pancreatic ductal adenocarcinoma (PDAC). Methods This single-center, retrospective study included 50 patients with resected PDAC who underwent both ctDNA testing and surveillance imaging between January 2015 and February 2025. Imaging included CT or CT/MRI of the chest, abdomen, and pelvis at 3–6 month intervals, with ctDNA testing performed on a similar schedule. Two abdominal radiologists independently reviewed all imaging for recurrence, defined by new or enlarging lesions; discrepancies were resolved by consensus. ctDNA recurrence was defined as the detection of tumor-specific mutations. Concordance was assessed at the patient level. Results Among 50 patients (median age 69.5 years, 33 men, 17 women), ctDNA and imaging were concordant in 39 (78%): 22 had recurrence and 17 did not. Discordance occurred in 11 patients, 10 of whom had radiologic recurrence with negative ctDNA. Most discordant lesions were located in the lung (n = 5, median size 0.4 cm) or surgical bed (n = 5, median size 2.0 cm). Radiologic recurrences preceded negative ctDNA test results in all 10 of these cases. One patient had positive ctDNA without imaging recurrence over 497 days of follow-up. At the organ level, 1/6 (17%) of lung metastases and 10/15 (67%) of local recurrences by imaging were detected by ctDNA. All lymph node, liver, peritoneal, and bone metastases were detected by ctDNA. Conclusion Positive ctDNA tests after PDAC resection correlates with radiologic recurrences in the lymph nodes, liver, peritoneum, and bones. However, radiologic recurrences in the lungs or surgical bed are commonly associated with a negative ctDNA test. Radiologists should scrutinize the latter two sites even when ctDNA tests are negative.
- 20 March 2026
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (10) , 1-9
Site-specific limitations of ctDNA in PDAC surveillance: imaging detects pulmonary and local recurrence missed by liquid biopsy
Objectives To evaluate the concordance between circulating tumor DNA (ctDNA) and imaging in the postoperative surveillance of patients with resected pancreatic ductal adenocarcinoma (PDAC). Methods This single-center, retrospective study included 50 patients with resected PDAC who underwent both ctDNA testing and surveillance imaging between January 2015 and February 2025. Imaging included CT or CT/MRI of the chest, abdomen, and pelvis at 3–6 month intervals, with ctDNA testing performed on a similar schedule. Two abdominal radiologists independently reviewed all imaging for recurrence, defined by new or enlarging lesions; discrepancies were resolved by consensus. ctDNA recurrence was defined as the detection of tumor-specific mutations. Concordance was assessed at the patient level. Results Among 50 patients (median age 69.5 years, 33 men, 17 women), ctDNA and imaging were concordant in 39 (78%): 22 had recurrence and 17 did not. Discordance occurred in 11 patients, 10 of whom had radiologic recurrence with negative ctDNA. Most discordant lesions were located in the lung (n = 5, median size 0.4 cm) or surgical bed (n = 5, median size 2.0 cm). Radiologic recurrences preceded negative ctDNA test results in all 10 of these cases. One patient had positive ctDNA without imaging recurrence over 497 days of follow-up. At the organ level, 1/6 (17%) of lung metastases and 10/15 (67%) of local recurrences by imaging were detected by ctDNA. All lymph node, liver, peritoneal, and bone metastases were detected by ctDNA. Conclusion Positive ctDNA tests after PDAC resection correlates with radiologic recurrences in the lymph nodes, liver, peritoneum, and bones. However, radiologic recurrences in the lungs or surgical bed are commonly associated with a negative ctDNA test. Radiologists should scrutinize the latter two sites even when ctDNA tests are negative.
- 1 February 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 318 (2) , e243477
Incidental Adnexal Lesions: CT Diagnosis and Interreader Agreement
Even among nine expert readers, CT diagnosis was not reproducible and was frequently incorrect for most adnexal lesion types, excluding dermoids, malignant ovarian lesions with metastases, and simple cysts.
- 1 February 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 318 (2) , e243477
Incidental Adnexal Lesions: CT Diagnosis and Interreader Agreement
Even among nine expert readers, CT diagnosis was not reproducible and was frequently incorrect for most adnexal lesion types, excluding dermoids, malignant ovarian lesions with metastases, and simple cysts.
- 9 December 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (7) , 3386-3395
Imaging surveillance outcomes of hepatocellular adenomas: systematic review and meta-analysis
Objectives Hepatocellular adenomas (HCA) are typically resected if > 5 cm after 6 months due to historical risks of bleeding and malignant transformation. Outcomes of contemporary patients managed with surveillance are not well defined. We performed a systematic review and meta-analysis of patients with HCAs monitored for ≥ 6 months to assess rates of size stability, bleeding, and malignant transformation. Methods PubMed, Web of Science, and Embase databases were searched up to August 2025 for all articles reporting HCA and follow-up. Risk of bias was assessed with modified Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I) tool. Pooled proportions of outcomes were assessed with linear mixed model and logistic regression. Heterogeneity was assessed with the I2 index. Results Of 679 articles screened, 7 retrospective studies (2019–2023) with 699 patients across Europe and United States were included. Five were multicenter. Median follow-up ranged from 2 to 5.8 years. For size stability, four studies used Response Evaluation Criteria in Solid Tumors (RECIST); others used a 1 cm size threshold, regression to < 5 cm, or unspecified criteria. Six studies showed moderate to serious risk of bias. Pooled proportion of HCAs that were stable or regressed was 88.5%. Pooled incidences of symptomatic bleeding and malignant transformation were 0.5% and 0.8%, respectively. Conclusion In a contemporary series, the majority of untreated HCAs were stable or regressed during surveillance, with extremely low incidences (< 1%) of bleeding and malignant transformation. Extending surveillance intervals may safely offer patients more time to address modifiable risk factors.
- 9 December 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (7) , 3386-3395
Imaging surveillance outcomes of hepatocellular adenomas: systematic review and meta-analysis
Objectives Hepatocellular adenomas (HCA) are typically resected if > 5 cm after 6 months due to historical risks of bleeding and malignant transformation. Outcomes of contemporary patients managed with surveillance are not well defined. We performed a systematic review and meta-analysis of patients with HCAs monitored for ≥ 6 months to assess rates of size stability, bleeding, and malignant transformation. Methods PubMed, Web of Science, and Embase databases were searched up to August 2025 for all articles reporting HCA and follow-up. Risk of bias was assessed with modified Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I) tool. Pooled proportions of outcomes were assessed with linear mixed model and logistic regression. Heterogeneity was assessed with the I2 index. Results Of 679 articles screened, 7 retrospective studies (2019–2023) with 699 patients across Europe and United States were included. Five were multicenter. Median follow-up ranged from 2 to 5.8 years. For size stability, four studies used Response Evaluation Criteria in Solid Tumors (RECIST); others used a 1 cm size threshold, regression to < 5 cm, or unspecified criteria. Six studies showed moderate to serious risk of bias. Pooled proportion of HCAs that were stable or regressed was 88.5%. Pooled incidences of symptomatic bleeding and malignant transformation were 0.5% and 0.8%, respectively. Conclusion In a contemporary series, the majority of untreated HCAs were stable or regressed during surveillance, with extremely low incidences (< 1%) of bleeding and malignant transformation. Extending surveillance intervals may safely offer patients more time to address modifiable risk factors.
- Open Access
- 22 September 2025
- Published by Wiley in Journal of Hospital Medicine
- Vol. 21 (2) , 183-196
Defining minimum image quality criteria for common diagnostic point‐of‐care ultrasound images: A position statement of the Society of Hospital Medicine
Background: Point‐of‐care ultrasound (POCUS) use continues to expand across multiple clinical subspecialties, and the need for standardization of training and quality assurance has become increasingly important. Despite the need for training, there are currently no widely accepted multispecialty criteria to define an acceptable quality POCUS image for common POCUS applications used by clinicians. Without such criteria, discrepancies in rating POCUS image quality occur, leading to inconsistencies in training and quality assurance, which can ultimately compromise patient care and safety. Methods: To address this gap, the Society of Hospital Medicine (SHM) Point‐of‐care Ultrasound Task Force convened an expert panel of 32 national POCUS experts trained in hospital medicine ( n = 24), critical care ( n = 4), emergency medicine ( n = 3), radiology ( n = 2), and cardiology ( n = 1) and employed a modified‐Delphi approach to develop minimum image quality criteria for five common POCUS applications: heart, lungs, abdomen, lower extremity veins, and skin/soft tissues. Results: After three rounds of voting and group discussion, the panel achieved consensus on a comprehensive list of 215 items to define standard image quality criteria in five different body systems. Conclusions: These POCUS image quality criteria offer a structured, consensus‐based framework for evaluating POCUS images and establish a minimum standard for defining an acceptable quality image. Use of these criteria can improve inter‐rater reliability and advance standardization of POCUS imaging, which affects training, quality assurance, and credentialing/privileging practices.
- 22 September 2025
- Published by Wiley in Journal of Hospital Medicine
- Vol. 21 (2) , 183-196
Open AccessDefining minimum image quality criteria for common diagnostic point‐of‐care ultrasound images: A position statement of the Society of Hospital Medicine
Background: Point‐of‐care ultrasound (POCUS) use continues to expand across multiple clinical subspecialties, and the need for standardization of training and quality assurance has become increasingly important. Despite the need for training, there are currently no widely accepted multispecialty criteria to define an acceptable quality POCUS image for common POCUS applications used by clinicians. Without such criteria, discrepancies in rating POCUS image quality occur, leading to inconsistencies in training and quality assurance, which can ultimately compromise patient care and safety. Methods: To address this gap, the Society of Hospital Medicine (SHM) Point‐of‐care Ultrasound Task Force convened an expert panel of 32 national POCUS experts trained in hospital medicine ( n = 24), critical care ( n = 4), emergency medicine ( n = 3), radiology ( n = 2), and cardiology ( n = 1) and employed a modified‐Delphi approach to develop minimum image quality criteria for five common POCUS applications: heart, lungs, abdomen, lower extremity veins, and skin/soft tissues. Results: After three rounds of voting and group discussion, the panel achieved consensus on a comprehensive list of 215 items to define standard image quality criteria in five different body systems. Conclusions: These POCUS image quality criteria offer a structured, consensus‐based framework for evaluating POCUS images and establish a minimum standard for defining an acceptable quality image. Use of these criteria can improve inter‐rater reliability and advance standardization of POCUS imaging, which affects training, quality assurance, and credentialing/privileging practices.
- 1 June 2025
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 45 (6) , e240182
US of the Neck beyond the Thyroid Gland: Parathyroid Glands
Preoperative assessment of parathyroid neoplasms is crucial for surgical planning, with US preferred for its detailed anatomic visualization, cost-effectiveness, absence of ionizing radiation, and ability to allow assessment of thyroid nodules concurrently during the hyperparathyroidism workup, helping determine a minimally invasive approach to parathyroidectomy.
- 1 June 2025
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 45 (6) , e240182
US of the Neck beyond the Thyroid Gland: Parathyroid Glands
Preoperative assessment of parathyroid neoplasms is crucial for surgical planning, with US preferred for its detailed anatomic visualization, cost-effectiveness, absence of ionizing radiation, and ability to allow assessment of thyroid nodules concurrently during the hyperparathyroidism workup, helping determine a minimally invasive approach to parathyroidectomy.
- 27 May 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (12) , 6119-6128
Qualitative assessment of hepatic steatosis on modern grayscale ultrasound: more accurate than previously thought?
Objective To assess the diagnostic performance of standardized qualitative assessment of hepatic steatosis on grayscale ultrasound. Methods This retrospective, single-center, multi-case, multi-reader study included 200 patients with ultrasound examinations of the liver. Three readers assessed hepatic steatosis based on a standardized system of 3 ultrasound features: presence of increased fine echoes, visualization of right hemidiaphragm, and visualization of portal triads, assigning a four-grade category (normal, mild, moderate, or severe). Magnetic resonance imaging proton density fat fraction (MRI-PDFF) was used as reference standard. Binary discrimination (normal vs. steatosis) was summarized with binary area under the curve (AUC), sensitivity, and specificity. Discrimination across four categories was performed with pairwise comparisons. Reader differences were tested with the Obuchowski-Rockette-Hillis model. Inter-reader agreement was calculated with Gwet’s agreement coefficient (AC). Results Of the 200 patients, 27% (54/200) had normal liver (MRI-PDFF < 5%), 35% (70/200) had mild steatosis (MRI-PDFF ≥ 5-17.4%), 15% (29/200) had moderate steatosis (MRI-PDFF > 17.4–22.1%), and 24% (47/200) had severe steatosis (MRI-PDFF > 22.1%). Median time interval between ultrasound and MRI exams was 4 days (IQR 1–28). Sensitivity, specific, and binary AUC for readers 1/2/3 were 90%/82%/94%, 65%/82%/54%, and 0.87/0.85/0.88 with no statistically significant difference between readers (p = 0.46). Four-class category analysis showed excellent performance of ultrasound to distinguish extreme categories (AUC > 0.95 for normal vs. severe). Inter-reader agreement was substantial (Gwet’s AC 0.63) for steatosis category assignment and moderate to substantial (Gwet’s AC 0.55–0.71) for ultrasound features. Conclusion Contrary to popular belief, qualitative ultrasound assessment of hepatic steatosis is accurate in detecting and grading steatosis when evaluation criteria are standardized.
- 27 May 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (12) , 6119-6128
Qualitative assessment of hepatic steatosis on modern grayscale ultrasound: more accurate than previously thought?
Objective To assess the diagnostic performance of standardized qualitative assessment of hepatic steatosis on grayscale ultrasound. Methods This retrospective, single-center, multi-case, multi-reader study included 200 patients with ultrasound examinations of the liver. Three readers assessed hepatic steatosis based on a standardized system of 3 ultrasound features: presence of increased fine echoes, visualization of right hemidiaphragm, and visualization of portal triads, assigning a four-grade category (normal, mild, moderate, or severe). Magnetic resonance imaging proton density fat fraction (MRI-PDFF) was used as reference standard. Binary discrimination (normal vs. steatosis) was summarized with binary area under the curve (AUC), sensitivity, and specificity. Discrimination across four categories was performed with pairwise comparisons. Reader differences were tested with the Obuchowski-Rockette-Hillis model. Inter-reader agreement was calculated with Gwet’s agreement coefficient (AC). Results Of the 200 patients, 27% (54/200) had normal liver (MRI-PDFF < 5%), 35% (70/200) had mild steatosis (MRI-PDFF ≥ 5-17.4%), 15% (29/200) had moderate steatosis (MRI-PDFF > 17.4–22.1%), and 24% (47/200) had severe steatosis (MRI-PDFF > 22.1%). Median time interval between ultrasound and MRI exams was 4 days (IQR 1–28). Sensitivity, specific, and binary AUC for readers 1/2/3 were 90%/82%/94%, 65%/82%/54%, and 0.87/0.85/0.88 with no statistically significant difference between readers (p = 0.46). Four-class category analysis showed excellent performance of ultrasound to distinguish extreme categories (AUC > 0.95 for normal vs. severe). Inter-reader agreement was substantial (Gwet’s AC 0.63) for steatosis category assignment and moderate to substantial (Gwet’s AC 0.55–0.71) for ultrasound features. Conclusion Contrary to popular belief, qualitative ultrasound assessment of hepatic steatosis is accurate in detecting and grading steatosis when evaluation criteria are standardized.
- 1 April 2025
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 45 (4) , e240102
Bowel Endometriosis: Systematic Approach to Diagnosis with US and MRI
Bowel endometriosis, most commonly involving the rectosigmoid colon, is best evaluated with transvaginal US with bowel preparation or with MRI, and knowledge of normal bowel anatomy and disease manifestations in different bowel segments and identification of coexisting sites of endometriosis are important for accurate diagnosis.
- 1 April 2025
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 45 (4) , e240102
Bowel Endometriosis: Systematic Approach to Diagnosis with US and MRI
Bowel endometriosis, most commonly involving the rectosigmoid colon, is best evaluated with transvaginal US with bowel preparation or with MRI, and knowledge of normal bowel anatomy and disease manifestations in different bowel segments and identification of coexisting sites of endometriosis are important for accurate diagnosis.